Baker Bros. Advisors LP Biomea Fusion, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 2,108,949 shares of BMEA stock, worth $14.9 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,108,949
Previous 2,108,949
-0.0%
Holding current value
$14.9 Million
Previous $31.5 Million
69.9%
% of portfolio
0.13%
Previous 0.4%
Shares
5 transactions
Others Institutions Holding BMEA
# of Institutions
120Shares Held
17.9MCall Options Held
978KPut Options Held
286K-
Cormorant Asset Management, LP Boston, MA3.57MShares$25.3 Million1.24% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$9.85 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.1MShares$7.79 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$5.66 Million1.57% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $207M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...